We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
-9.53%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$8.52B
AUM Growth
-$320M
Cap. Flow
+$757M
Cap. Flow %
8.89%
Top 10 Hldgs %
11.37%
Holding
608
New
127
Increased
223
Reduced
94
Closed
151

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$73.3M
2
HPQ icon
HP
HPQ
+$72.4M
3
ATVI
Activision Blizzard
ATVI
+$69.4M
4
DTV
DIRECTV COM STK (DE)
DTV
+$61.8M
5
ZBH icon
Zimmer Biomet
ZBH
+$57.9M

Sector Composition

Rank Sector Weight
1 Industrials 17.99%
2 Financials 14.52%
3 Technology 14.34%
4 Healthcare 13.66%
5 Energy 9.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLXP
351
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$1.54M 0.02%
13,760
-2,490
-15% -$287K
HII icon
352
Huntington Ingalls Industries
HII
$12.8B
$1.52M 0.02%
+14,232
New +$1.62M
OMG
353
DELISTED
OM GROUP INC.
OMG
$1.47M 0.02%
+44,769
New +$1.51M
PBPB
354
DELISTED
Potbelly
PBPB
$1.47M 0.02%
133,577
+32,553
+32% +$390K
SIOX
355
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$1.47M 0.02%
14,220
-1,405
-9% -$165K
BLOX
356
DELISTED
Infoblox Inc
BLOX
$1.45M 0.02%
+90,538
New +$1.98M
RBBN icon
357
Ribbon Communications
RBBN
$383M
$1.44M 0.02%
250,914
+914
+0.4% +$6.16K
QNST icon
358
QuinStreet
QNST
$1.21B
$1.43M 0.02%
258,125
+46,863
+22% +$275K
OOMA icon
359
Ooma
OOMA
$604M
$1.43M 0.02%
+205,680
New +$1.92M
ADAP
360
DELISTED
Adaptimmune Therapeutics
ADAP
$1.42M 0.02%
118,419
-11,434
-9% -$162K
EPZM
361
DELISTED
Epizyme, Inc
EPZM
$1.4M 0.02%
108,772
-44,352
-29% -$895K
TEVA icon
362
Teva Pharmaceuticals
TEVA
$41.2B
$1.38M 0.02%
+24,515
New +$1.59M
AVDL
363
DELISTED
Avadel Pharmaceuticals
AVDL
$1.36M 0.02%
83,255
+42,282
+103% +$931K
ATRS
364
DELISTED
Antares Pharma, Inc.
ATRS
$1.34M 0.02%
789,416
+173,126
+28% +$339K
PSG
365
DELISTED
Performance Sports Group Ltd.
PSG
$1.34M 0.02%
+100,000
New +$1.52M
AIMT
366
DELISTED
Aimmune Therapeutics
AIMT
$1.27M 0.01%
+50,000
New +$1.17M
TOL icon
367
Toll Brothers
TOL
$14.5B
$1.25M 0.01%
36,553
+17,262
+89% +$654K
GNCA
368
DELISTED
Genocea Biosciences, Inc.
GNCA
$1.25M 0.01%
22,771
+19,971
+713% +$1.98M
WCIC
369
DELISTED
WCI Communities, Inc.
WCIC
$1.22M 0.01%
54,092
+27,799
+106% +$669K
EGN
370
DELISTED
Energen
EGN
$1.22M 0.01%
24,497
-225,503
-90% -$12.2M
BLRX
371
BioLineRX
BLRX
$11.8M
$1.21M 0.01%
1,319
+92
+7% +$98.2K
MOBL
372
DELISTED
MobileIron, Inc.
MOBL
$1.2M 0.01%
388,025
+142,108
+58% +$654K
NGNE icon
373
Neurogene
NGNE
$712M
$1.19M 0.01%
4,221
-697
-14% -$161K
ASND icon
374
Ascendis Pharma A/S
ASND
$16.8B
$1.19M 0.01%
67,079
+6,139
+10% +$120K
SEDG icon
375
SolarEdge
SEDG
$1.95B
$1.19M 0.01%
+51,738
New +$1.45M

Similar funds

Alyeska Investment Group's Q3 2015 Portfolio in Review

As of Q3 2015, Alyeska Investment Group held 608 positions worth $8.52B, down 3.6% from $8.84B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Alyeska Investment Group deployed $757M of net new capital in Q3 2015, opening 127 new positions and adding to 223 existing holdings. Its largest new stake was SUNEDISON, INC COM: 5,924,743 shares worth $42.5M.

By sector, the portfolio is most concentrated in Industrials at 18% of assets, up from 14% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was HP, an estimated $72.4M trimmed.

  • Alyeska Investment Group's largest Q3 2015 buy was SUNEDISON, INC COM: 5,924,743 shares worth $42.5M.
  • Alyeska Investment Group added most to NorthStar Realty Finance Corp. in Q3 2015, an estimated $75.1M increase.
  • Alyeska Investment Group's biggest Q3 2015 reduction was HP, cutting an estimated $72.4M.
  • Alyeska Investment Group fully exited Cigna in Q3 2015, selling an estimated $73.3M.
  • Alyeska Investment Group's ten largest holdings make up 11% of its $8.52B portfolio in Q3 2015.
  • Alyeska Investment Group opened 127 new positions and closed 151 in Q3 2015.
  • Alyeska Investment Group's portfolio value fell 3.6% quarter-over-quarter to $8.52B.

Based on Alyeska Investment Group's 13F filing for Q3 2015, filed 16 Nov 2015.